SGLT2 Inhibitors May Lead to Better Kidney Outcomes Than GLP-1 Drugs

JAMA 2026

View at publisher

Authors: Samantha Anderer

DOI: 10.1001/jama.2025.26385

Cited by: 0

Fields of Study & Subjects

Diabetes Treatment and Management Chronic Kidney Disease and Diabetes Acute Kidney Injury Research